Gender differences in short-term effects of atorvastatin on lipid profile, fibrinolytic parameters, and endothelial function

This publication has 31 references indexed in Scilit:

• Effects of Atorvastatin Therapy on the Low-Density Lipoprotein Subfraction, Remnant-Like Particles Cholesterol, and Oxidized Low-Density Lipoprotein Within 2 Weeks in Hypercholesterolemic Patients
  Circulation Journal, 2003
• Effects of atorvastatin on oxidized low-density lipoprotein, low-density lipoprotein subfraction distribution, and remnant lipoprotein in patients with mixed hyperlipoproteinemia
  The American Journal of Cardiology, 2002
• Improved fibrinolysis after 1-year treatment with HMG CoA reductase inhibitors in patients with coronary heart disease
  Thrombosis Research, 2002
• Rapid effects on vascular function after initiation and withdrawal of atorvastatin in healthy, normocholesterolemic men
  The American Journal of Cardiology, 2001
• Effect of Statin Therapy on Remnant Lipoprotein Cholesterol Levels in Patients With Combined Hyperlipidemia
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2001
• Effects of atorvastatin on lipid profile and coagulation parameters
  Current Therapeutic Research, 2001
• Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolemia (ASAP): a prospective, randomised, double-blind trial
  The Lancet, 2001
• Short-Term Atorvastatin Treatment Improves Endothelial Function in Hypercholesterolemic Women
  Journal of Cardiovascular Pharmacology, 2000
• Effect of atorvastatin and fluvastatin on the expression of plasminogen activator inhibitor type-1 in cultured human endothelial cells
  Atherosclerosis, 2000
• Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells.
  Journal of Clinical Investigation, 1998